Patent Yard Sign in
Canadian application, no grantCanada

Biallelic markers of d-amino acid oxidase and uses thereof

CA 2469923 A1 · Owner: Cohen, Daniel · Inventors: Chumakov, Ilya; Cohen, Daniel

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The invention concerns the human DAO gene polynucleotides, and biallelic , markers. The invention also concerns the association established between schizophrenia and the biallelic markers. The invention provides means to determine the predisposition of individuals to schizophrenia or related CNS disorder, as well as means for the disease diagnosis and prognosis.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed October 29, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 29, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 29, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledOctober 29, 2002
GrantedNo grant recorded
Term endedOctober 29, 2022
Patent numberCA 2469923 A1
Classification (IPC)C12Q1/68

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedOct 29, 2002Term endedOct 29, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.